quantisnow
FeedTopReportsPricing
⌘K
Live feed
16:06:16·23d
SECFiling
Omeros Corporation logo

SEC Form 10-K filed by Omeros Corporation

OMER· Omeros Corporation
Health Care
Full content unavailable. See the original source below.
Original source

Companies

  • OMER
    Omeros Corporation
    Health Care

Recent analyst ratings

  • Jun 10UpdateH.C. Wainwright$9.00
  • Dec 23UpdateD. Boral Capital$36.00
  • Nov 14UpdateRodman & Renshaw$9.00
  • Dec 8UpdateUBS$2.00
  • Nov 8UpdateBofA Securities$3.00
  • Jun 8UpdateBofA Securities$4.00

Related

  • SEC19h
    Amendment: SEC Form SCHEDULE 13G/A filed by Omeros Corporation
  • PR3d
    Sagimet Biosciences Announces Appointment of Andreas Grauer, MD, as Chief Medical Officer
  • PR7d
    CMS Assigns Permanent Reimbursement J-Code for YARTEMLEA® (narsoplimab-wuug)
  • SEC23d
    Omeros Corporation filed SEC Form 8-K: Results of Operations and Financial Condition, Financial Statements and Exhibits
  • PR23d
    Omeros Corporation Reports Fourth Quarter and Year-End 2025 Financial Results
  • SEC27d
    Amendment: SEC Form SCHEDULE 13G/A filed by Omeros Corporation
  • PR28d
    Omeros Corporation to Announce Fourth Quarter and Full-Year 2025 Financial Results on March 31, 2026
  • PR34d
    Omeros Announces Upcoming Presentation at EBMT 2026 Highlighting Advances in TA-TMA Treatment
quantisnow

Real-time market intelligence for retail investors. Press releases, filings, ratings, and insider flow - all in one stream.

All systems operational

Feeds

Press releasesAnalyst ratingsInsider tradingFDASECRSS feeds

Top lists

TrendingBy market capActive companiesAnalyst upgradesInsider purchasesFDA approvalsSEC filingsSectorsMarket reports

Company

AboutPricingPublish with usContact

Legal

Terms of usePrivacy policyCookie policy

© 2026 quantisnow.com · Democratizing insights since 2022